[
    {
        "example_id": 13,
        "problem": [
            "ChIP-seq on a PFA-fixed sample with an antibody to the IKAROS transcription factor in human B cells followed by next-generation sequencing and standard quality control, alignment and peak-calling steps produced ChIP peaks that disappeared when PFA+DSG fixation was used. Where are we most likely to find such disappearing peaks?",
            "At active promoters and enhancers",
            "At repeats",
            "In the introns of large genes",
            "At random locations in the genome",
            0
        ],
        "correct_answer": 0,
        "n": "abstracted_workflow_2_13",
        "response": "IKAROS binds specifically at promoters/enhancers and genuine sites remain under stringent DSG+PFA crosslinking. Peaks lost with DSG+PFA represent weak or nonspecific interactions, typical of repetitive elements. Thus disappearing peaks map to repeats.\n\nAnswer:B)",
        "sub_tasks_text": null
    },
    {
        "example_id": 13,
        "problem": [
            "ChIP-seq on a PFA-fixed sample with an antibody to the IKAROS transcription factor in human B cells followed by next-generation sequencing and standard quality control, alignment and peak-calling steps produced ChIP peaks that disappeared when PFA+DSG fixation was used. Where are we most likely to find such disappearing peaks?",
            "At active promoters and enhancers",
            "At repeats",
            "In the introns of large genes",
            "At random locations in the genome",
            0
        ],
        "correct_answer": 0,
        "n": "abstracted_workflow_8_13",
        "response": "All debate agents agree that indirect IKAROS interactions disrupted by stronger PFA+DSG crosslinking are most prevalent at active promoters and enhancers. Thus the top disappearing peaks map to those regulatory regions.\n\nAnswer:A)",
        "sub_tasks_text": null
    }
]